Advertisement

Topics

Synergenz BioScience Ltd Company Profile

12:24 EST 19th February 2019 | BioPortfolio

Synergenz BioScience Ltd is a research leader in genomic tests for respiratory medicine. It was formed in 2004 to further advance discoveries first made by Dr. Robert Young at The University of Auckland in New Zealand, where studies continue in collaboration with leading researchers and the company's commercial partners around the world.


News Articles [339 Associated News Articles listed on BioPortfolio]

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment

Arix Bioscience Plc - Arix Bioscience announces first VIPE investment PR Newswire London, August 5 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATIO...

Aytu BioScience, Inc.: Aytu BioScience Announces Pricing of $13.2 Million Underwritten Public Offering

ENGLEWOOD, CO / ACCESSWIRE / October 5, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant ...

Aytu BioScience, Inc.: Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

ENGLEWOOD, CO / ACCESSWIRE / October 10, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significant...

Twist Bioscience Files for $86.3M IPO

Today, Twist Bioscience filed an S-1 with the U.S. Securities and Exchange Commission (SEC), announcing its intent to undergo an initial public offering. The filing shows that Twist intends to raise $...

Aytu BioScience, Inc.: Aytu BioScience to Present at 11th Annual LD Micro Main Event Investor Conference on December 5, 2018

ENGLEWOOD, CO / ACCESSWIRE / November 27, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products addressing significan...

Aytu BioScience, Inc.: Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio

Company Posts Highest Ever Quarterly Revenue ENGLEWOOD, CO / ACCESSWIRE / November 7, 2018 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on global commercializa...

Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to ...

Cyclenium Pharma Inc.Helmut Thomas, Ph.D., DABT, +1-819-571-4296President, CEO & CSOhthomas@cyclenium.comorHaplogen Bioscience GmbHGeorg Casari, Ph.D., +43-1-9165522Chief Exec...

Aytu BioScience, Inc.: Aytu BioScience Announces Publication of Manuscript Summarizing Results from the Ongoing Natesto(R) Spermatogenesis Study

Sperm Concentration, Motility, and Total Motile Sperm Count Remain Within Normal Ranges in Hypogonadal Men Taking Natesto ENGLEWOOD, CO / ACCESSWIRE / September 17, 2018 / Aytu BioScience, Inc. (NA...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Idkit hp one [exalenz bioscience ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

Natesto [aytu bioscience, inc.]

These highlights do not include all the information needed to use NATESTO safely and effectively. See full prescribing information for NATESTO.Natesto (testosterone) nasal gel CIII Initial U.S. Approv...

PubMed Articles [64 Associated PubMed Articles listed on BioPortfolio]

Editorial: Bioscience of D-amino Acid Oxidase From Biochemistry to Pathophysiology.

Correction: Proteasome subunit-α type-6 protein is post-transcriptionally repressed by the microRNA-4490 in diabetic nephropathy.

Improving Undergraduate Life Science Education for the Biosciences Workforce: Overcoming the Disconnect between Educators and Industry.

The BioHealth Capital Region (Maryland, Virginia, and Washington, DC; BHCR) is flush with colleges and universities training students in science, technology, engineering, and mathematics disciplines a...

Correction: The potential role of MGMT rs12917 polymorphism in cancer risk: an updated pooling analysis with 21010 cases and 34018 controls.

Association between three genetic variants in kallikrein 3 and prostate cancer risk.

Epidemiological studies have assessed the association between kallikrein 3 (KLK3) polymorphisms and prostate cancer (PCa) susceptibility. However, published data on this association are somewhat incon...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose li...

Companies [314 Associated Companies listed on BioPortfolio]

Synergenz BioScience, Inc.

Synergenz BioScience, Inc. was established to further develop technologies first discovered by Dr. Robert Young at Auckland University in New Zealand and in collaboration with lea...

Synergenz BioScience Ltd

Synergenz BioScience Ltd is a research leader in genomic tests for respiratory medicine. It was formed in 2004 to further advance discoveries first made by Dr. Robert Young at The...

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

Bioscience Bridge, LLC

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...

More Information about "Synergenz BioScience Ltd" on BioPortfolio

We have published hundreds of Synergenz BioScience Ltd news stories on BioPortfolio along with dozens of Synergenz BioScience Ltd Clinical Trials and PubMed Articles about Synergenz BioScience Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synergenz BioScience Ltd Companies in our database. You can also find out about relevant Synergenz BioScience Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...


Corporate Database Quicklinks



Searches Linking to this Company Record